Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
12/23/1999 | WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof |
12/23/1999 | WO1999066038A1 Angiostatin-binding protein |
12/23/1999 | WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12 |
12/23/1999 | WO1999065530A1 NrdD |
12/23/1999 | WO1999065520A1 Egg surface proteins and methods for use for modulating fertility |
12/23/1999 | WO1999065517A2 Therapeutic compositions that produce an immune response by altering the antigen |
12/23/1999 | WO1999065515A2 Combination of radiotherapy and anti-angiogenic factors |
12/23/1999 | WO1999065513A2 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders |
12/23/1999 | WO1999065501A1 A process for the treatment of organophosphate poisoning |
12/23/1999 | WO1999065500A1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination |
12/23/1999 | WO1999065489A1 Methods for increasing levels of acetylcholine |
12/23/1999 | WO1999065470A1 Particulate acellular tissue matrix |
12/23/1999 | WO1999065466A1 Temperature-sensitive liposomal formulation |
12/23/1999 | WO1999065462A2 Use of aminosterol derivatives as chloride ionphores |
12/23/1999 | WO1999065456A1 Foaming composition for hair care |
12/23/1999 | WO1999065309A1 Methods for increasing levels of acetylcholine |
12/23/1999 | WO1999065307A1 Methods and compositions for treatment of aids-associated kaposi's sarcoma |
12/23/1999 | WO1999053043A3 Herpes simplex virus latency associated transcript polypeptides |
12/23/1999 | WO1999052516A3 Acylpeptide protease inhibitors to enhance cognitive function |
12/23/1999 | WO1999042578A3 Modulation of cell proliferation, methods and reagents |
12/23/1999 | WO1999039722A3 Compositions and methods for separating lens epithelial cells and preventing posterior capsular opacification |
12/23/1999 | DE19852804C1 Pharmaceutical composition for manipulating angiogenesis |
12/23/1999 | DE19825591A1 Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata Pharmaceutical combinations to offset a deficit testosterone in men with prostate while protecting the |
12/23/1999 | CA2335295A1 Methods for increasing levels of acetylcholine |
12/23/1999 | CA2335038A1 Combination of radiotherapy and anti-angiogenic factors |
12/23/1999 | CA2334805A1 Use of aminosterol derivatives as chloride ionphores |
12/23/1999 | CA2333453A1 Methods for increasing levels of acetylcholine |
12/23/1999 | CA2333221A1 Therapeutic compositions that produce an immune response by altering the antigen |
12/23/1999 | CA2332997A1 A process for the treatment of organophosphate poisoning |
12/23/1999 | CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof |
12/23/1999 | CA2331889A1 Nek-related and bub1-related protein kinases |
12/23/1999 | CA2331834A1 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders |
12/23/1999 | CA2331382A1 Interaction of p27(kip1) with fkbp-12 |
12/23/1999 | CA2330840A1 Diagnostic method based on quantification of extramitochondrial dna |
12/23/1999 | CA2330228A1 Angiostatin-binding protein |
12/23/1999 | CA2330210A1 Proteasomal activity |
12/23/1999 | CA2301665A1 Methods and compositions for treatment of aids-associated kaposi's sarcoma |
12/22/1999 | EP0965623A1 Stabilized monomer adhesive compositions |
12/22/1999 | EP0965351A2 Pharmaceutical composition for treating side-effects of a diet with reduced amount of carbohydrates |
12/22/1999 | EP0965341A2 Combination of dofetilide and a calcium channel blocker |
12/22/1999 | EP0965278A1 Dietetic food composition and dietetic method using such composition |
12/22/1999 | EP0964921A1 Novel streptococcal ers |
12/22/1999 | EP0964917A1 Age-1 polypeptides and related molecules and methods |
12/22/1999 | EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
12/22/1999 | EP0964697A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene |
12/22/1999 | EP0964686A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
12/22/1999 | EP0964682A1 A method of treating liver disease and like indications with vasodilating agents |
12/22/1999 | EP0964680A1 Use of nitric oxide inhibitors for treating side effects of particulate drugs |
12/22/1999 | EP0964679A1 Method for the treatment of neurological or neuropsychiatric disorders |
12/22/1999 | EP0964678A1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions |
12/22/1999 | EP0964617A1 Structure-based rational design of compounds to inhibit papillomavirus infection |
12/22/1999 | EP0910385A4 Sensitization of cells to radiation and chemotherapy |
12/22/1999 | EP0910362A4 Oxa acids and related compounds for treating skin conditions |
12/22/1999 | EP0876160B1 Ligand directed enzyme prodrug therapy |
12/22/1999 | EP0711167A4 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict |
12/22/1999 | CN1239437A Mitochondrial membrane stabilizer |
12/22/1999 | CN1239433A Methods and compsns. for stimulating neurite growth using compounds with affinity for PKBP12 in combination with neurotrophic factors |
12/22/1999 | CN1047507C Bevrage and enriched beverage for enhancing bioavailability of beta-carotene |
12/22/1999 | CA2274741A1 Use of a compound having an affinity for the mitochondrial benzodiazepine receptor in cancer therapy |
12/21/1999 | US6005080 Nucleotide sequences and expression vectors encoding hu-b1.219 gene product; molecular probes designed from its nucleotide sequence may be useful for prenatal testing and cancer diagnosis |
12/21/1999 | US6005074 Cloning of human GPR14 receptor |
12/21/1999 | US6005020 Bioresorbable compositions for implantable prostheses |
12/21/1999 | US6004993 N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses |
12/21/1999 | US6004987 Use of ligands which are specific for RXR receptors |
12/21/1999 | US6004972 Therapeutic process for the treatment of the pathologies of type II diabetes |
12/21/1999 | US6004970 Administering with nicotine and drug enhancer |
12/21/1999 | US6004953 Administering synergistic mixture of ascorbic acid and cobalt or iron phthalo- or naphthalocyanine complex; side effect reduction; anticarcinogenic agents; catalysis |
12/21/1999 | US6004945 Use of adenosine compounds to relieve pain |
12/21/1999 | US6004927 Coadministering bioenhancer comprising inhibior of cytochrome p450 3a or p-glycoprotein-mediated membrane transport |
12/21/1999 | US6004803 Genes encoding HSV1-TK containing a deletion of 5' cryptic promoter sites, vectors and cell lines |
12/21/1999 | US6004792 Amino acid sequence of enzyme which controls intracellular lipids; for antiinflammatory/antiproliferative/ anticarcinogenic agents; diagnosis and prevention of autoimmune, gastrointestinal, and cardiovascular disorders |
12/21/1999 | US6004764 Screening methods for potential therapeutic agents which regulate the growth of m. tuberculosis; method for identifying genes of m. tuberculosis which are regulated by a sigma factor of m. tuberculosis |
12/21/1999 | US6004746 Interaction trap systems for detecting protein interactions |
12/21/1999 | US6004565 Administering fingolimod hydrochloride |
12/21/1999 | US6004559 Plant material is extracted using an organic solvent, preferably acetone, then saturated with reducing agent acids to reduce toxic ndga quinone, which naturally occurs in the plant material, to ndga; antiinflammatory, antiviral agents |
12/21/1999 | US6004554 Methods for targeting the vasculature of solid tumors |
12/21/1999 | US6004552 Administration of a monoclonal antibody capable of binding to a human cd40 antigen located on the surface of a human b cell, wherein the binding of the antibody to the cd40 antigen prevents the growth or differentiation of the b cell |
12/21/1999 | US6004550 Intracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug system |
12/21/1999 | US6003516 Method for treatment of cancer and infectious disease |
12/16/1999 | WO1999065228A2 Pharmaceutical combination used to compensate for a testosterone deficiency while protecting the prostate |
12/16/1999 | WO1999064606A1 Tankyrase, a trfi binding protein |
12/16/1999 | WO1999064596A2 Proteins regulating gene expression |
12/16/1999 | WO1999064593A2 Cell cycle regulation proteins |
12/16/1999 | WO1999064570A1 Novel methods and interferon deficient substrates for the propagation of viruses |
12/16/1999 | WO1999064469A1 FIXATION INHIBITORS FOR $i(HELICOBACTER PYLORI) |
12/16/1999 | WO1999064464A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
12/16/1999 | WO1999064463A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples |
12/16/1999 | WO1999064435A1 The human kidney specific gene kk86 |
12/16/1999 | WO1999064395A1 Heterocyclic amide compounds as cell adhesion inhibitors |
12/16/1999 | WO1999064378A2 Directed combinatorial compound library and high throughput assays for screening same |
12/16/1999 | WO1999064068A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
12/16/1999 | WO1999064061A1 GLUCAGON-LIKE PEPTIDE-1 IMPROVES β-CELL RESPONSE TO GLUCOSE IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE |
12/16/1999 | WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
12/16/1999 | WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS |
12/16/1999 | WO1999064052A1 Novel leukotriene receptor antagonists and their uses |
12/16/1999 | WO1999064050A1 Novel potassium channel drugs and their uses |
12/16/1999 | WO1999064045A1 Novel therapeutic agents for membrane transporters |
12/16/1999 | WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
12/16/1999 | WO1999064041A1 Multibinding agents that modulate nmda receptors |
12/16/1999 | WO1999064038A1 Novel analgesic agents |